CG
MIRM icon

Caprock Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Caprock Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Sell
3,034
-2,563
-46% -$241K 0.01% 948
2025
Q4 		$442K Buy
5,597
+819
+17% +$58.8K 0.01% 866
2025
Q3 		$353K Buy
+4,778
New +$304K 0.01% 899

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Caprock Group's MIRM Position: Q1 2026 in Review

Caprock Group reduced its Mirum Pharmaceuticals (MIRM) stake by 46% in Q1 2026, selling an estimated $241K and leaving 3,034 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #948.

Caprock Group first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. The position peaked at $442K in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Caprock Group held 3,034 shares of Mirum Pharmaceuticals worth $280K as of Q1 2026.
  • Caprock Group sold 2,563 Mirum Pharmaceuticals shares in Q1 2026, an estimated $241K.
  • Mirum Pharmaceuticals made up 0.01% of Caprock Group's portfolio in Q1 2026, its #948 holding.
  • Caprock Group first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Caprock Group's Mirum Pharmaceuticals position peaked at $442K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.